Bridging preclinical to commercial manufacturing in cell therapy: mind the gap

Authors

Institutions

Publication Details

Journal
Cell and Gene Therapy Insights
Published
2025-09-18
DOI
https://doi.org/10.18609/cgti.2025.162
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bridging preclinical to commercial manufacturing in cell therapy: mind the gap

Aundy Kumar, Jaichandran Sivalingam, S. Hamza
Cell and Gene Therapy Insights
CAR-T cell therapy research
article

Bridging preclinical to commercial manufacturing in cell therapy: mind the gap

Aundy Kumar, Jaichandran Sivalingam, S. Hamza
article en

Abstract

No abstract available for this paper.
Cell and Gene Therapy InsightsVol. 11(8)
Agency for Science, Technology and Research (SG), Incell Corporation (United States) (US), Bioprocessing Technology Institute (SG)
Openalex Percentile: Top 45%
CAR-T cell therapy research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Bridging preclinical to commercial manufacturing in cell therapy: mind the gap — Aundy Kumar, Jaichandran Sivalingam, et al. · Cell and Gene Therapy Insights (2025) | TGRS Research Map | TGRS